pharmaceuticals

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Shares of Pfizer Inc. (NYSE: PFE) rose about 1.3% in afterhours trading Thursday after the company announced that the U.S. Food and Drug Administration (FDA) had approved Xeljanz (tofacitinib) for ...
Read Full Story »

Teva Pharmaceuticals: Happy Holidays, You’re Fired

Another company has decided that the best time to fire a large number of people is just before the holidays. While there are some concrete reasons to do so, the ...
Read Full Story »

Investors Can’t Seem to Make Up Their Minds on Teva’s Restructuring

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday. Previously, investors had responded positively ...
Read Full Story »

Why Cellectis Is Winning Big With Its Pfizer Partnership

Shares of Cellectis S.A. (NASDAQ: CLLS) saw a handy gain early on Wednesday after the firm announced preliminary data from its two Phase 1 studies in conjunction with Pfizer Inc. ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Will Consumers Trust Generic Viagra?

If there is one drug from pharmaceutical giants that may have changed the world in lifestyle, Viagra might be the first one that comes to mind. It has helped millions ...
Read Full Story »

Will Alexion Pharmaceuticals Fight This Activist?

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock. ...
Read Full Story »

Arrowhead Pharma Wins in Midstage Hepatitis Study

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) saw its shares make a handy gain early Wednesday after the firm presented new data from its midstage study for the treatment of hepatitis B ...
Read Full Story »

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

With 2017 coming to an end, investors are wondering how they should be investing for 2018 and beyond. At the start of December, the Dow was up just over 20% ...
Read Full Story »

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

With the market looking ready to continue running to all-time highs despite yesterday's selling, many pundits feel this late stage part of the rally is more people trying to get ...
Read Full Story »

Will Teva’s Restructuring Stop the Bleeding?

Shares of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) rose Monday after the company announced a reorganization some of its top leadership positions. This stock has been brutalized in 2017, and ...
Read Full Story »

Achillion Pharmaceuticals Gears Up for Secondary Offering

Shares of Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) saw a handy gain on Thursday after the company announced a secondary offering. While the offering is set to close on November 20, ...
Read Full Story »

Short Sellers Back Way Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

3 Companies Spearheading the Antibiotics Space in 2018

This may turn out to be a pivotal year in antibiotic development, after decades of dramatic decline in the space. While 1980 to 1984 saw 18 new antibiotic approvals, the ...
Read Full Story »

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

During the presidential campaign of 2015–2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Spending on pharmaceuticals when the population ...
Read Full Story »